FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 3.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $66,000 | +450.0% | 10,833 | +625.1% | 0.00% | – |
| Q2 2021 | $12,000 | -94.6% | 1,494 | -90.8% | 0.00% | -100.0% |
| Q3 2019 | $223,000 | +291.2% | 16,264 | +249.9% | 0.00% | +100.0% |
| Q2 2019 | $57,000 | -62.7% | 4,648 | -65.5% | 0.00% | 0.0% |
| Q4 2018 | $153,000 | +264.3% | 13,482 | +493.9% | 0.00% | – |
| Q3 2018 | $42,000 | -81.5% | 2,270 | -77.6% | 0.00% | -100.0% |
| Q1 2018 | $227,000 | +530.6% | 10,117 | +610.5% | 0.00% | – |
| Q4 2017 | $36,000 | -76.6% | 1,424 | -77.6% | 0.00% | -100.0% |
| Q3 2017 | $154,000 | +5033.3% | 6,371 | +4091.4% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 152 | -28.3% | 0.00% | – |
| Q2 2016 | $3,000 | -89.3% | 212 | -93.0% | 0.00% | – |
| Q1 2016 | $28,000 | -75.0% | 3,019 | -48.1% | 0.00% | -100.0% |
| Q4 2015 | $112,000 | +62.3% | 5,819 | +26.0% | 0.00% | 0.0% |
| Q3 2015 | $69,000 | – | 4,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |